Welcome to TNBC Early Detection Discovery Center
|
Triple negative breast cancer (TNBC), which accounts for 10-15% of all breast cancers has defied treatments effective in other cancers and is arguably the most aggressive breast cancer sub-type. Fundamental approaches to deciphering longitudinal mechanisms that lead to cancer initiation, its progression, and its metastasis would help in identifying stage and etiology-specific next generation therapeutics. Our major outcomes will include state- and stage-specific characterization of mechanism, identification of markers, development of TNBC models, and identification of mechanistic phenotypic modules (endotypes) associated with stage-specific TNBC |
For more information on TNBC, please refer to the fact sheet on TNBC from Centers for Disease Control and Prevention (CDC)
